Journal Article Ppublish 2 citations
PubMed: 39574946 DOI: 10.26502/aimr.0184
Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome.
Arch Intern Med Res 7(4):273-283
Authors: Ritika Patial, Irene Batta, Manish Thakur, Ranbir Chander Sobti, Devendra K Agrawal
Affiliations
- Centre for System Biology & Bioinformatics, Panjab University, Chandigarh, India.
- Bothell High School, Bothell, Washington, USA.
- School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, Punjab, India.
- Department of Biotechnology, Panjab University, Chandigarh, India.
- Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
Abstract
Metabolic Syndrome (MetS) is a complex cluster of metabolic irregularities that significantly increase the risk of developing chronic conditions, such as hypertension, type 2 diabetes, cardiovascular diseases, and other related disorders. This review aims to provide a comprehensive overview of the current understanding of MetS, its etiology and underlying pathogenesis, and the management strategies. MetS is characterized by central obesity, high blood pressure, insulin resistance, hyperglycemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels. The prevalence of MetS is remarkably high, affecting approximately 25% of the global population, particularly in developed nations with inactive lifestyles and high-calorie diets. The development of MetS involves genetic and acquired factors, resulting in an inflammatory state that enhances the risk for cardiovascular disease. The biochemical alterations observed in MetS establish pathological connections between MetS, diabetes, and cardiovascular and neurodegenerative conditions. Despite its clinical importance, there is still debate regarding the precise components and pathophysiological associations among MetS elements. However, advancements in therapeutic measures, including drug therapies, surgical options, and experimental methods present promising avenues for managing and potentially reversing MetS. Further investigation of the MetS is critical because of its significant implications for public health and its connection to other clinical conditions and severe health outcomes, placing a substantial burden on healthcare system and society.
MeSH
Diabetes Mellitus, Hypertension, Cardiovascular Diseases, Therapeutics, Metabolic Syndrome
Cited by
- Impact of Maternal Ultra-Processed Food Consumption and Preterm Birth on the Development of Metabolic Disorders in Offspring. J Pediatr Perinatol Child Health, 2025
- Effect of Metabolic Syndrome in the incidence of Rotator Cuff Injury and Recovery following Surgical Repair. J Surg Res (Houst), 2025
- Prevalence of Metabolic Syndrome Among Students: Associations with Dietary Habits, Physical Activity, and Sociodemographic Factors. J Clin Med, 2025
- The Counteracting Effect of Chrysin on Dietary Fructose-Induced Metabolic-Associated Fatty Liver Disease (MAFLD) in Rats with a Focus on Glucose and Lipid Metabolism. Molecules, 2025
- Delitesâ„¢ supplementation prevents metabolic syndrome onset and modulates gut microbiome in male Sprague Dawley rats fed on cholesterol- and fat-enriched diet: a randomized preclinical trial study. Front Nutr, 2025
- Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health. Cardiol Cardiovasc Med, 2025
- CDC42 Regulatory Patterns Related To Inflammatory Bowel Disease and Hyperglycemia. J Bioinform Syst Biol, 2025